Prothena Corporation plc
PRTA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $525 | $327 | $666 | $745 |
| - Cash | $331 | $371 | $418 | $471 |
| + Debt | $9 | $10 | $10 | $11 |
| Enterprise Value | $204 | -$35 | $259 | $285 |
| Revenue | $2 | $4 | $3 | $2 |
| % Growth | -45.4% | 56.3% | 33.2% | – |
| Gross Profit | -$27 | $4 | $3 | $2 |
| % Margin | -1,098.3% | 100% | 100% | 100% |
| EBITDA | -$36 | -$52 | -$65 | -$65 |
| % Margin | -1,488.2% | -1,171.5% | -2,311.1% | -3,046.4% |
| Net Income | -$37 | -$126 | -$60 | -$58 |
| % Margin | -1,513.1% | -2,845.4% | -2,128.5% | -2,729.9% |
| EPS Diluted | -0.68 | -2.34 | -1.12 | -1.08 |
| % Growth | 70.9% | -108.9% | -3.7% | – |
| Operating Cash Flow | -$41 | -$46 | -$53 | -$48 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$41 | -$46 | -$53 | -$48 |